These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25917799)

  • 1. Varicella zoster virus immunity: A primer.
    Duncan CJ; Hambleton S
    J Infect; 2015 Jun; 71 Suppl 1():S47-53. PubMed ID: 25917799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.
    Haberthur K; Engelmann F; Park B; Barron A; Legasse A; Dewane J; Fischer M; Kerns A; Brown M; Messaoudi I
    PLoS Pathog; 2011 Nov; 7(11):e1002367. PubMed ID: 22102814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.
    Schub D; Janssen E; Leyking S; Sester U; Assmann G; Hennes P; Smola S; Vogt T; Rohrer T; Sester M; Schmidt T
    J Infect Dis; 2015 Feb; 211(4):600-12. PubMed ID: 25180236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the treatment of varicella-zoster virus infections.
    Andrei G; Snoeck R
    Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
    van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
    J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
    Diaz PS; Smith S; Hunter E; Arvin AM
    J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular studies of Varicella zoster virus.
    Quinlivan M; Breuer J
    Rev Med Virol; 2006; 16(4):225-50. PubMed ID: 16791838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of virus-specific CD4+ T cells on reexposure to Varicella-Zoster virus.
    Vossen MT; Gent MR; Weel JF; de Jong MD; van Lier RA; Kuijpers TW
    J Infect Dis; 2004 Jul; 190(1):72-82. PubMed ID: 15195245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for varicella-zoster virus infections.
    Andrei G; Snoeck R
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella-zoster virus immunizes patas monkeys against simian varicella-like disease.
    Felsenfeld AD; Schmidt NJ
    J Gen Virol; 1979 Jan; 42(1):171-8. PubMed ID: 215708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivation of Simian Varicella Virus in Rhesus Macaques after CD4 T Cell Depletion.
    Traina-Dorge V; Palmer BE; Coleman C; Hunter M; Frieman A; Gilmore A; Altrock K; Doyle-Meyers L; Nagel MA; Mahalingam R
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30404798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive Roles for Type I and Type II Interferons and Interferon Regulatory Factors in the Host Cell Defense against Varicella-Zoster Virus.
    Sen N; Sung P; Panda A; Arvin AM
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30089701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular pathogenesis of varicella virus infection.
    Gilden DH; Cohrs RJ; Mahalingam R
    Viral Immunol; 2003; 16(3):243-58. PubMed ID: 14583142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha.
    Ku CC; Zerboni L; Ito H; Graham BS; Wallace M; Arvin AM
    J Exp Med; 2004 Oct; 200(7):917-25. PubMed ID: 15452178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrabronchial infection of rhesus macaques with simian varicella virus results in a robust immune response in the lungs.
    Haberthur K; Meyer C; Arnold N; Engelmann F; Jeske DR; Messaoudi I
    J Virol; 2014 Nov; 88(21):12777-92. PubMed ID: 25142604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
    Arvin AM; Sharp M; Smith S; Koropchak CM; Diaz PS; Kinchington P; Ruyechan W; Hay J
    J Immunol; 1991 Jan; 146(1):257-64. PubMed ID: 1670603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
    Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation.
    Merindol N; Salem Fourati I; Brito RM; Grenier AJ; Charrier E; Cordeiro P; Caty M; Mezziani S; Malette B; Duval M; Alfieri C; Ovetchkine P; Le Deist F; Soudeyns H
    J Immunol; 2012 Nov; 189(10):5016-28. PubMed ID: 23034171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.